CNFN — what changed in the latest 10-Q
A section-by-section comparison of CNFN's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-26 vs the prior 10-Q · 2026-05-20
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +13 | −12 | ~3 | 13 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Other information | Text added/removed | 0 | −3 | ~4 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Market risk (Item 3), Legal proceedings, Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-26
The following are the results of our continuing operations for the six months ended June 30, 2026 as compared to the six months ended June 30, 2025:
Net revenues from continuing operations were $48,598 for the three months ended June 30, 2026, compared to $6,302 for the three months ended June 30, 2025, an increase of $42,296. For the six months ended June 30, 2026, net revenues from continuing operations were $136,515, compared to $8,585 for th…
Cost of revenue from continuing operations was $31,852 for the three months ended June 30, 2026, compared to $100 for the three months ended June 30, 2025. For the six months ended June 30, 2026, cost of revenue was $89,099, compared to $352 for the six months ended June 30, 2025. The increase in bo…
Selling, general and administrative expenses from continuing operations were $1,349,714 for the three months ended June 30, 2026, compared to $337,955 for the three months ended June 30, 2025, an increase of $1,011,759. For the six months ended June 30, 2026, selling, general and administrative expe…
Loss from continuing operations was $1,332,968 for the three months ended June 30, 2026, compared to $331,753 for the three months ended June 30, 2025. For the six months ended June 30, 2026, loss from continuing operations was $2,528,812, compared to $793,653 for the six months ended June 30, 2025.…
Text removed vs the prior filing · source: 10-Q · 2026-05-20
Net revenues from continuing operations were $87,917 for the three months ended March 31, 2026, compared to $2,283 for the three months ended March 31, 2025, an increase of $85,634. The increase was primarily attributable to the addition of the wine and beverage operations following the acquisitions…
Cost of revenue from continuing operations was $57,247 for the three months ended March 31, 2026, compared to $252 for the three months ended March 31, 2025, an increase of $56,995. Cost of revenue consists primarily of the cost of wine and beverage products sold and related shipping, freight and de…
Selling, general and administrative expenses from continuing operations were $1,226,514 for the three months ended March 31, 2026, compared to $463,931 for the three months ended March 31, 2025, an increase of $762,583. The increase was primarily attributable to (i) stock-based compensation and sett…
Loss from continuing operations was $1,195,844 for the three months ended March 31, 2026, compared to $461,900 for the three months ended March 31, 2025, an increase in loss of $733,944. The increase was primarily due to the higher selling, general and administrative expenses described above, partia…
Total other expense, net, from continuing operations was $38,490 for the three months ended March 31, 2026, compared to $54,248 for the three months ended March 31, 2025. The change reflects (i) interest expense of $55,108 for the three months ended March 31, 2026 compared to $54,248 for the three m…
Other information
Text removed vs the prior filing · source: 10-Q · 2026-05-20
Given the timing of the events, the following information is included in this Form 10-Q pursuant to Item 3.02 “Unregistered Sales of Equity Securities” and pursuant to Item 5.02 “Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers” of Form 8-K in lieu of filing a Form 8-K.
On May 20, 2026, the Company issued to each of Brian Ross, the Company’s President and Chief Executive Officer and a director, and Mario Marsillo Jr., the Company’s Chief Business Officer and a director, ten year warrants exercisable at any time following the issue date to purchase up to 500,000 sha…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice